Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2023-2025
Title: Nils Engelbogen: Innovator in Radiolabelling Technology
Introduction
Nils Engelbogen is a prominent inventor based in Kiel, Germany. He has made significant contributions to the field of radiolabelling technology, holding a total of 2 patents. His work focuses on the development of marking precursors that incorporate advanced chemical compounds for various applications.
Latest Patents
Engelbogen's latest patents include innovative methods for creating marking precursors with squaric acid coupling. The first patent details a marking precursor that incorporates a chelator or fluorination group for radiolabelling with a variety of isotopes, including 44Sc, 47Sc, and 99mTc, among others. This invention also features one or two biological targeting vectors that are coupled to the chelator or fluorinating group via squaric acid groups. The second patent similarly relates to marking precursors with squaric acid coupling, emphasizing the versatility and importance of these compounds in radiolabelling.
Career Highlights
Throughout his career, Engelbogen has worked with notable companies such as Scv Spezial-Chemikalien-Vertriebs GmbH and Telix Pharmaceuticals Limited. His experience in these organizations has allowed him to refine his expertise in chemical engineering and radiochemistry, contributing to advancements in medical imaging and treatment.
Collaborations
Engelbogen has collaborated with esteemed colleagues in his field, including Frank Rösch and Lukas Greifenstein. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Nils Engelbogen is a key figure in the realm of radiolabelling technology, with a focus on innovative marking precursors. His contributions have the potential to enhance medical applications significantly.